AVOIDING LUNG COMPLICATIONS FOR PATIENTS POST-SURGERY Improved patient recovery in muscle relaxant reversal drug, according to Specialist anaesthetist-led SNaPP study
With
Professor Kate Leslie AO,
Specialist anaesthetist, Royal Melbourne Hospital &
Honorary Professor, University of Melbourne &
Member, ANZCA Clinical Trials Network
RESEARCH TO PRACTICE SEGMENT
Filmed in Melbourne | October 2026
A “hidden pandemic” of lung complications after surgery has been highlighted by an international study led by Australian researchers that has found how a newer muscle relaxant reversal drug can help improve patient recovery.
The findings of the SNaPP Study (Sugammadex, Neostigmine and Postoperative Pulmonary complications), led by the Department of Critical Care, Melbourne Medical School, University of Melbourne and the Australian and New Zealand College of Anaesthetists (ANZCA) Clinical Trials Network (CTN) were published in The Lancet Respiratory Medicine in June 2026 (https://doi.org/10.1016/S2213-2600(26)00158-X).
Forty-four hospitals and 3500 patients in Australia, New Zealand and Hong Kong were involved in the four-year study, which received $2.9 million from the Medical Research Future Fund (MRFF).
The study’s Principal Investigator, specialist anaesthetist Professor Kate Leslie AO, spoke to Australian Health Journal and said the study answers one of the most hotly debated questions in anaesthesia:
“Lung complications can increase the need for oxygen after surgery and cause distress to patients. By reversing muscle relaxant drugs more effectively, sugammadex helps patients breathe more deeply and prevents collapse of lung tissue,” she said.
Professor Leslie said the trial findings highlighted a “hidden global pandemic” of lung complications for many patients after surgery.
However, while collapse of lung tissue was common, more serious lung complications such as pneumonia were infrequent. There were also no differences in the need for intensive care treatment or length of hospital stay between the two groups of patients studied.
The SNaPP Study recruited patients aged 40 years and older having abdominal or thoracic surgery.
“The study results will have immediate benefits for patients and healthcare systems,” she said.
Source: Adapted from Australian and New Zealand College of Anaesthetists (ANZCA) media release (June 2026)
-
Cardiologist broadens Tasmania’s surgical abilities
Dr Heath Adams is a Tasmanian born, bred and educated interventional and structural cardiologist who works at Hobart Private and Royal Hobart Hospital and is a researcher through the Menzies Research Institute.
Dr Adams clinical interest and expertise is in the management of aortic stenosis, valvular heart disease and acute coronary syndromes. Dr Adams performs coronary interventions including stenting, and structural heart interventions including TAVI, mitral edge to edge repair, mitral valve replacement and left atrial appendage closure. In 2020, Heath performed the first TAVI in Tasmania, is the clinical lead for the local program at the Royal Hobart Hospital and is a nationally accredited TAVI practitioner.
-
Psychiatrists to discuss connectedness at RANZCP 2023 Congress
Next week, at the Perth Convention and Exhibition Centre, The Royal Australian and New Zealand College of Psychiatrists (RANZCP) meet for the RANZCP 2023 Congress on the theme of “New Horizons: Connected Futures”
Australian Health Journal spoke to current President-Elect Dr Elizabeth Moore and soon to be President, RANZCP about the Congress, as well as the recent Federal Budget announcements around mental health funding.
-
Global Women’s Health report identifies concerning drop in Australian breast cancer screening
The Hologic Global Women’s Health Index is one of the largest global reports dedicated exclusively to women’s health and wellbeing. Now in its fifth year, the Index tracks women’s health across five dimensions , Preventive Care, Emotional Health, Opinions of Health and Safety, Basic Needs and Individual Health – across 144 countries and territories, covering 97 per cent of the global adult population.
